ArticlePostepy dermatologii i alergologii2023

The "real-world" effectiveness and safety of omalizumab in patients with uncontrolled persistent allergic asthma in Slovakia: a subgroup analysis of the eXpeRience study.

Simona Siracká et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.